Literature DB >> 16803507

Clinical and histopathologic factors related to prognosis in primary squamous cell carcinoma of the vagina.

K Hellman1, M Lundell, C Silfverswärd, B Nilsson, A-C Hellström, B Frankendal.   

Abstract

The goal of this retrospective study concerning primary carcinoma of the vagina (PCV) was to analyze clinical and histopathologic prognostic factors in one of the largest known material, which comprised 314 patients. PCV is a rare disease, and the majority of published studies are based on small materials; therefore, the established knowledge concerning prognostic factors is insufficient. Routine treatment is based on irradiation with risk for undertreatment or overtreatment, which leads to unnecessary complications in the absence of prognostic factors. The overall 5-year disease-specific survival rate in this study was 45% and in stage I 75%. In the univariate statistical analysis, several factors correlated significantly with disease-specific survival. However, in the multivariate analysis, there were only three factors that independently could predict poor survival-high age at diagnosis, large tumors (> or =4 cm), and advanced stage. Common background factors with no prognostic significance were prior hysterectomy, other gynecological malignancies, and pelvic irradiation. In conclusion, this study has elucidated three strong prognostic factors that might be considered in the choice of therapy and also for modification of the FIGO guidelines. Increased knowledge concerning complementary biologic markers to discriminate between low- and high malignant tumors is however of great importance.

Entities:  

Mesh:

Year:  2006        PMID: 16803507     DOI: 10.1111/j.1525-1438.2006.00520.x

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  11 in total

1.  Radiotherapy for vaginal cancer: a multi-institutional survey study of the Japanese Radiation Oncology Study Group.

Authors:  Hitoshi Ikushima; Masaru Wakatsuki; Takuro Ariga; Yuko Kaneyasu; Sunao Tokumaru; Fumiaki Isohashi; Noriko Ii; Takashi Uno; Tatsuya Ohno; Kokichi Arisawa; Takafumi Toita
Journal:  Int J Clin Oncol       Date:  2017-10-30       Impact factor: 3.402

2.  Prognostic Factors in Primary Vaginal Cancer: A Single Institute Experience and Review of Literature.

Authors:  Chelakkot G Prameela; Rahul Ravind; Bharath C Gurram; V S Sheejamol; Makuny Dinesh
Journal:  J Obstet Gynaecol India       Date:  2015-05-09

Review 3.  [HPV-associated alterations of the vulva and vagina. Morphology and molecular pathology].

Authors:  L-C Horn; K Klostermann; S Hautmann; A K Höhn; M W Beckmann; G Mehlhorn
Journal:  Pathologe       Date:  2011-11       Impact factor: 1.011

Review 4.  [Interdisciplinary S2k guidelines on the diagnosis and treatment of vaginal carcinoma and its precursors-recommendations on surgical pathology for histopathological workup, diagnostics, and reporting].

Authors:  Lars-Christian Horn; Anne Kathrin Höhn; Monika Hampl; Grit Mehlhorn; Markus Follmann; Hans-Georg Schnürch
Journal:  Pathologe       Date:  2021-02       Impact factor: 1.011

Review 5.  Primary vaginal cancer: role of MRI in diagnosis, staging and treatment.

Authors:  C S Gardner; J Sunil; A H Klopp; C E Devine; T Sagebiel; C Viswanathan; P R Bhosale
Journal:  Br J Radiol       Date:  2015-05-12       Impact factor: 3.039

6.  Factors affecting risk of mortality in women with vaginal cancer.

Authors:  Chirag A Shah; Barbara A Goff; Kimberly Lowe; William A Peters; Christopher I Li
Journal:  Obstet Gynecol       Date:  2009-05       Impact factor: 7.661

7.  Radiotherapy for carcinoma of the vagina. Immunocytochemical and cytofluorometric analysis of prognostic factors.

Authors:  P Blecharz; M Reinfuss; J Ryś; J Jakubowicz; P Skotnicki; W Wysocki
Journal:  Strahlenther Onkol       Date:  2013-04-05       Impact factor: 3.621

8.  Long-term results of radiotherapy in primary carcinoma of the vagina.

Authors:  Stefan Hegemann; Ulrich Schäfer; Ralph Lellé; Normann Willich; Oliver Micke
Journal:  Strahlenther Onkol       Date:  2009-03-28       Impact factor: 3.621

Review 9.  The burden of HPV-associated anogenital cancers.

Authors:  Katie Wakeham; Kimberley Kavanagh
Journal:  Curr Oncol Rep       Date:  2014-09       Impact factor: 5.945

10.  Human papillomavirus, p16(INK4A), and Ki-67 in relation to clinicopathological variables and survival in primary carcinoma of the vagina.

Authors:  K Hellman; D Lindquist; C Ranhem; E Wilander; S Andersson
Journal:  Br J Cancer       Date:  2014-02-13       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.